WIKIFARMER
9.2.2023 08:34:50 CET | Business Wire | Press release
Wikifarmer, the direct farmer-to-business agricultural marketplace—aptly described as the “Wikipedia of farming”—has raised a €5M in a late seed round, led by Point Nine.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230208005806/en/
Ilias Sousis and Petros Sagkos, founders of Wikifarmer (Photo: Business Wire)
The Athens-based startup will use the funding for pan-European expansion and to enrich its knowledge library. It will further enhance its platform to fully digitize transactions end-to-end, and offer innovative financial and logistic solutions to both buyers and sellers.
As a whole, Wikifarmer is an ecosystem that supports farmers from start to finish. It enables them to learn, sell and make their business lives easier.
On the supply side, farmers receive the value they deserve: they produce more efficiently, sell directly, and enjoy an increase in their profitability by up to 300%. Higher profitability for farmers means a higher capacity for investments in production, higher employment, and higher sustainability.
On the demand side, Wikifarmer acts as a purchasing assistant for B2B buyers, such as wholesalers, larger hotels, restaurant chains, small and medium size retailers, or food processing units. It provides hassle-free sourcing of agricultural products, helps parties to negotiate prices efficiently online, offers logistics support, ensures security and transaction transparency and facilitates 60 - 90 days of credit.
What’s next?
“Our vision is to restructure the supply chain, digitize processes, and ultimately generate more value for all parties involved. Our mission is to become Europe’s leading B2B trading platform within the next two years. This round of funding will allow us to accelerate our product development in order to offer 360° coverage of agricultural transactions” explains Wikifarmer’s Co-Founder and CEO, Ilias Sousis.
Petros Sagos, Co-Founder and Chief Science Officer, concludes: “Above all, we hope this funding will enable us to turn our long-standing vision into reality: democratize agriculture and support farmers in modernizing their techniques, selling their products, and earning the value they deserve"
Point 9 is a B2B SaaS and B2B marketplace-specialized VC firm with investments such as Revolut, Delivery Hero, Docplanner, and cargo.one and one of the highest “seed-to-winner” rates in the industry. The round was complemented by relevant Business Angels (the founders of cargo.one, Nikos Moraitakis - co-founder and CEO of Workable, Przemyslaw Budkowski - CEO of Merxu, Cihan Aksakal - founder of Zenjob, Louis Pfizner - founder of Caya.com and Treatwell), as well as prior investors including leading Greek VC Metavallon, plus angels such as Sophia Bendz.
“B2B marketplaces, which bring mostly analog industries online, are a core area of focus for us at Point Nine. We have been partnering with one or two new B2B marketplaces every year, for the last 7 years, including REKKI (restaurants) in 2016, Container xChange (containers) and Laserhub (metal parts) in 2017, cargo.one (air cargo) in 2018, MerXu (industrial products) in 2019, Rooser (seafood) in 2020, and now Wikifarmer. The food industry is gigantic and presents its own challenges, but we’ve been impressed by Ilias’s and Peter’s unique approach to digitizing the industry. We’re excited to play a small role in their long-term success” says Louis Coppey, partner at Point Nine.
The Industry and Context
In addition to being the no.1 employer[1] in the world, the agrifood industry generates a total turnover of 1.2 trillion Euros in Europe alone[2] and has a major impact on the everyday life of every single person on the planet. Yet, a significant number of farmers still lack access to modern agricultural best practices, and it remains one of the least digitized sectors. The pandemic, the outbreak of the war in Ukraine, along with climate change, population growth predictions, and the scarcity of natural resources have all had a major impact on the supply chain, and eventually, the food on our plates. The past few years have been challenging for the agrifood sector, placing increased demands on food security and sustainable solutions. Wikifarmer responds to the need for new technologies and ideas that have the potential to reshape agriculture, and this is reflected in the startup’s growth.
The Product
Wikifarmer is an ecosystem of content and agricultural products that promote a fairer, more transparent and sustainable value chain in the food industry. With Wikifarmer, farmers can sell their output to multiple buyers, achieve a better price, monitor fair market prices, and access international markets. The startup also offers instant payments to farmers and helps them with logistics and financing, allowing them to increase their profitability on the Wikifarmer marketplace. At the same time, it provides them with a wide collection of agricultural best practices and how-to guides, which have been translated into 16 languages and are freely accessible on the Wikifarmer Library.
On the platform, farmers can use the Wikifarmer library to upgrade their techniques, in order to improve the quality of their produce and boost their efficiency. Then, they can upload their products on the Wikifarmer Market and sell directly to buyers from all over the world.
The story behind the startup
Looking back to where everything started, the founding team is a metaphor for Wikifarmer's mission: matching digitization with agricultural science. CEO Ilias Sousis, a senior ex-Googler for 11 years, and Chief Science Officer Petros Sagos, an accomplished agronomist, have been best friends since primary school. "We started Wikifarmer because we thought things should be done differently" they explain.
Today, Wikifarmer is approaching 1m unique visitors per month. It has allowed thousands of businesses to slash costs by up to 30%, enabling farmers to sell their products without intermediaries, while growing their potential clientele, reducing waste, and tripling their profitability. The Wikifarmer library has been dubbed the “Wikipedia of Farming” by the United Nations and is now available in 16 languages.
About Wikifarmer
Wikifarmer is a global platform whose mission is to empower farmers by offering them education as well as direct access to commercial markets, so they can sell their products at fair prices.
About Point Nine
Founded in 2011, Point Nine is a European early-stage venture capital firm focused on B2B SaaS and B2B marketplace start-ups in Europe and North America. The firm is a seed investor in more than 150 companies in over 30 countries, including Algolia, Brainly, Chainalysis, Clio, Contentful, Delivery Hero, DocPlanner, Front, Loom, Mambu, Revolut, and Typeform, amongst others. Point Nine has one of the highest “seed-to-winner” rates in the industry.
About Metavallon
Metavallon VC specializes in pre-seed and seed-stage funding of disruptive technology companies. The firm invests in and works alongside ambitious entrepreneurs, helping them build transformational businesses across multiple stages, geographies and industries. Metavallon VC’s mission is to engage at a very early stage and invest in companies that will operate at the forefront of business and technology innovation.
[1] United Nations, 2017
[2] https://www.opendei.eu/agri-food-sector/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005806/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
